ozogamicin
sirukumab
vobarilizumab
Ab
immunotarget
Forssman antibody
-o-
leronlimab
tucotuzumab
anticorrelate
immunoturbidometric
seroimmunity
serospecific
sonepcizumab
immunodeposit
hyperimmunoglobulin
elotuzumab
immunoepidemiological
lenzilumab
immunofluorographic
agonistic monoclonal antibody
muromonab
casirivimab
immunoprobe
mapatumumab
antimonoclonal
immunoabsorptive
glembatumumab
immunoprophylactic
mepolizumab
immunoreacting
immunochemical
sotrovimab
drozitumab
tislelizumab
immunoepidemiology
olaratumab
briakinumab
brolucizumab
immunoassayable
immunofluorohistochemical
IgM
pidilizumab
immunoconvert
immunopotentiative
immunoresistant
abagovomab
gevokizumab
ravulizumab